Are pediatric drug errors occurring in your ED? Act now before tragedy strikes

    Insights

    Pediatric emergency department (ED) errors, often weight-based dosing mistakes, can be reduced. Implementing standardized protocols and pharmacist reviews can improve medication safety for children.

    Area of Science:

    • Pediatric Emergency Medicine
    • Medication Safety
    • Pharmacology

    Background:

    • Children face significant risks of medical errors in emergency departments (EDs).
    • Weight-based dosing inaccuracies are a primary cause of these medication errors.

    Purpose of the Study:

    • To identify strategies for reducing medication errors in pediatric EDs.
    • To address the specific challenge of weight-based dosing errors.

    Main Methods:

    • Standardizing medication protocols by reducing drug variety, concentrations, formulations, and suppliers.
    • Implementing mandatory pharmacist review of all ED prescriptions.
    • Requiring double-checks by nurses or physicians for high-risk medications, including sedatives.

    Main Results:

    • The proposed interventions aim to decrease the frequency and severity of medication errors.
    • Standardization and verification processes are expected to enhance patient safety.
    • Pharmacist involvement is crucial for accurate medication management.

    Conclusions:

    • Reducing medication errors in pediatric EDs requires a multi-faceted approach.
    • Standardization of medications and rigorous verification processes are key to improving safety.
    • Pharmacist oversight is essential for mitigating dosing errors in vulnerable pediatric populations.

    Related Concept Videos

    Pharmaceutical Poisoning: Potential Scenarios01:26

    Pharmaceutical Poisoning: Potential Scenarios

    Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
    Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

    Pharmacokinetics in Pediatric Patients: Drug Excretion

    In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
    Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

    Pharmacokinetics in Pediatric Patients: Drug Distribution

    Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
    Drug Dosing: Infants and Children01:29

    Drug Dosing: Infants and Children

    Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
    Drug Regulation01:25

    Drug Regulation

    Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
    Drug Toxicity: Risk factors01:24

    Drug Toxicity: Risk factors

    Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...